Kevin Krenitsky, MD
STRATEGIC ADVISOR
Previously, he served as President of Enzo Clinical Labs and instituted a strategic plan to launch numerous FDA-approved esoteric tests. He served as CEO at both BioServe Biotechnologies, a global biotechnology company, and Parkway Clinical Laboratories, a clinical diagnostic lab. He also has held senior-level positions with Genomics Collaborative, Inc., a clinical and genomics research company.
Dr. Krenitsky received a Bachelor of Science in Business Management from the University of Scranton and a Medical Degree from Jefferson Medical College, Philadelphia. He currently serves on the Board of Directors of several life science companies, including Lumicell, a technology leader developing systems to enable surgeons to see residual cancer cells in the cavity walls in real-time during surgery.

HOW NEW THERAPIES REACH PATIENTS FASTER
© Copyright 2021 Inteliquet™, Inc. All rights reserved.
